Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Gilead Sciences (GILD) stock price has staged a strong comeback this year, helped by strong earnings and a recent $40 million ...

根据最新提交给美国证券交易委员会的文件显示，Gilead Sciences, Inc. (NASDAQ:GILD) 首席医疗官Merdad ...

Piper Sandler维持对Gilead Sciences (NASDAQ: GILD)的"增持"评级，目标价为95.00美元。 该公司的分析是在世界肺癌大会 (WCLC)关于各种TROP2靶向ADC项目（包括Gilead Sciences的项目 ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

In the latest supply deal on the active pharmaceutical ingredients (API) front, Gilead Sciences has tapped South Korea’s ...

Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...

Defendant Yisel Lopez has been found in contempt for violating an asset freeze order through the sale of property.

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Shares of Gilead Sciences Inc. GILD dropped 0.13% to $83.05 Tuesday, on what proved to be an all-around mixed trading session ...

坎托菲茨杰拉德公司：重申Gilead Sciences(GILD.US)评级，由中性调整至中性评级, 目标价由70.00美元调整至70.00美元。 吉利德科学（GILD.US）公司简介：吉利德科学公司（Gilead Sciences，Inc.）是一家生物制药公司，致力于在医疗需求未得到满足的领域进行药物的研究 ...